Whitsell Innovations, Inc. to Exhibit at Drug Information Association (DIA) 2019 Annual Meeting

Whitsell Innovations, Inc. to Exhibit at Drug Information Association (DIA) 2019 Annual Meeting


Chapel Hill, NC – 14 June 2019 – Whitsell Innovations, Inc. to Exhibit at Drug Information Association (DIA) 2019 Annual Meeting

Whitsell Innovations (WI), Inc., will be one of the exhibitors at DIA 2019 Annual Meeting scheduled to be held from June 23-27, 2019 in San Diego, California.

Director of Business Development, Tom McPhatter; Senior Medical Writer and Manager, Karen Campbell, MS; and Business Development Associates Natalie Becker and Regina Luppi, MBA, will staff WI booth number 1140. President and founder of WI and member of the DIA Annual Program Committee, Robin Whitsell, will also be in attendance.

The team will be available to discuss WI’s medical writing experience and outsourcing best practices for pharmaceutical, biotech, and device companies including the documentation required for submissions to the Food and Drug Administration (FDA) and international regulatory bodies during the pre-clinical and clinical development process. They will be available to advise on electronic filings with the FDA (eCTD filing requirements), the updated transparency and lay summary requirements for the EU, and the requirements for public release of submission documents. They will also address how industry clients use medical writers to share clinical data in manuscripts, training materials, and presentations.

“The DIA meeting is a fantastic opportunity to share best practices,” says Ms. Whitsell. “The conversations we have at this meeting with health authorities and other industry professionals are invaluable.”

WI members will also be available to discuss the trends in the writing of clinical study reports (CSRs), the approaches to streamlining periodic adverse safety update reports (PADERs), and regulatory updates associated with the use of the period benefit-risk evaluation report (PBRER). They will also be available to discuss cGMP regulations and rest-of-world filings.

“Exhibiting at DIA provides a great opportunity to connect with our current and potential customers,” says Ms. Becker. “As a company with a rich telecommuter culture, being at DIA gives us a chance to speak with our customers face-to-face enriching those connections.”

DIA is a global volunteer and member community representing thousands of life science professionals working together to bring innovative, safe and effective medical products to patients. An association of more than 30,000 key stakeholders, DIA, founded as the Drug Information Association, builds productive relationships by bringing together regulators, life sciences professionals, academics and researchers, patient advocates and other influencers to exchange knowledge and collaborate in a neutral setting.


WI is a Women’s Business Enterprise National Council (WBENC) certified woman owned full-service medical, scientific, and technical writing company headquartered in Chapel Hill, North Carolina.

Contact: info@whitsellinnovations.com

Website: www.whitsellinnovations.com

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company’s control. Whitsell Innovations, Inc.’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.